AB2 Bio will receive $30 million from Nippon Shinyaku after [...]

PolyPid’s D-PLEX100 has been granted FDA Priority Review following acceptance [...]

Qureight has raised $20 million in a Series B financing [...]

ProBioGen and VarmX have entered a collaboration to develop a [...]

China’s growing biotechnology sector is facing increased scrutiny from US [...]

AI-driven antibody discovery could create a $7 billion market opportunity [...]

Pace Life Sciences has completed a US FDA inspection of [...]

CAMP4 Therapeutics has received Australian regulatory and ethics clearance to [...]

Deep Origin’s computational platform helped identify a molecular glue compound [...]

Samsung Biologics has announced plans to acquire peptide CDMO PolyPeptide [...]